Trial intelligence / Profile preview

GRAFTT

DRKS00003551Phase 4Recruiting

Sponsor
Charité – Universitätsmedizin Berlin
Start
May 2013
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of tacrolimus in hepatic failure and liver transplant (3 arms), sponsored by Charité – Universitätsmedizin Berlin. Started May 2013; status: recruiting.

02

Drugs

tacrolimus
03

Conditions

hepatic failureliver transplant

Beyond the preview

Go deeper on DRKS00003551.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00003551.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call